NantHealth has validated successful DeviceConX™ integration with Baxter’s Prismaflex system, used to treat critically-ill patients in the ICU Connectivity is being used in multiple U.S. hospitals ...
Baxter International Inc. BAX recently announced the global launch of the latest version of its next-generation platform, PrisMax 2. The PrisMax 2 system aims to help streamline the delivery of ...
Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ST Set used in continuous renal ...
VIENNA--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a global leader in acute care therapies, announced today the commercial launch of a new indication for the company’s oXiris set, which ...
EXETER — Exeter Hospital’s Intensive Care Unit was recently able to purchase two Baxter Prismaflex Systems thanks to a generous donation from a family who was looking to support treatment for patients ...
Baxter International, a global leader in acute care, announced it has received Emergency Use Authorizations (EUAs) from the US Food and Drug Administration (FDA) for the company’s HF20 Set and ST Set ...
* BAXTER INTERNATIONAL INC - HAS BOOSTED ITS CAPACITY AND PRODUCTION TO HELP ADDRESS HIGHER DEMAND FOR PRODUCTS INCLUDING PRISMAX AND PRISMAFLEX * BAXTER INTERNATIONAL - SINCE EMERGENCE OF COVID-19, ...
Baxter International Inc. BAX recently announced the global launch of the latest version of its next-generation platform, PrisMax 2. The PrisMax 2 system aims to help streamline the delivery of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results